Please do not leave this page until complete. This can take a few moments.
The UMass Medical School received a $10-million donation for the study of rare diseases such as ALS, cystic fibrosis and Huntington's.
The gift -- one of the largest ever for the school -- came from a Chinese businessman with no previous connection to UMass. Li Weibo said health research is one way in which his wants to give half of his money away over his life.
"This is just the beginning. I will continue my support," Li said through Guanping Gao, a professor at the Medical School who acted as a translator.
Li's donation will establish the Li Weibo Institute for Rare Disease Research at the medical school, which already has researchers working toward discoveries on some of the world's rarest diseases. Li is also giving $750,000 a year to cover the costs of five Chinese students in the Graduate School of Biomedical Sciences.
The donation, which was announced Tuesday evening, comes just a week after the school said it received a $2-million gift for ALS and neuroscience research from from Diane Riccio and her husband, Dan, is the largest the school has received from an alum. The couple also gave $1 million four years ago.
Li's gift to UMass is the first he has made to an American university. Li's business, Glory Harvest Group, includes real estate development, mining, e-commerce, biotechnology and other fields. He started his namesake foundation in 2013.
Li first connected with UMass Medical School Chancellor Michael Collins a few years ago, Collins said, but Li didn't visit campus for the first time until June, when he was in Boston. Collins invited Li to a dinner at his home with UMass researchers, and Li said he was attracted to the school by Collins's charm and hearing of the disease studies going on at the school.
"I was quite struck with the sincerity in which he made his donation," Collins said, calling it extraordinary that he would make such a large contribution so soon after visiting campus.
UMass researchers have making progress on rare-disease research including a breakthrough last year on ALS, also known as Lou Gehrig's disease. For patients and their families though, UMass often has to deliver the news that there still isn't anything that can be done today, Collins said.
On behalf of those patients, Collins said to Li, "I cannot begin to express my gratitude."
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments